Chitooligosaccharides induce apoptosis in human breast cancer cells
Mohan Krishna Mallakuntla, Vasudevarao Penugurti, Bramanandam Manavathi and 1 more
Carbohydrate Polymer Technologies and Applications · 2021
doi:10.1016/j.carpta.2021.100077 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
In this study, biologically active chitooligosaccharides (COS) D3–7 (D-deacetylated unit) and A5 (A-acetylated unit) were assessed for their suitability to reduce the viability of human breast cancer cell lines, BT-474 and SUM-159. The treatment with COS resulted in a significant decrease in the viability of breast cancer cells, in a dose-dependent manner. The long-term proliferative potential of breast cancer cells decreased upon COS treatment, suggesting that COS significantly inhibited colony formation in breast cancer cells. The COS-treated cell population significantly underwent apoptosis, confirmed by flow cytometry. Further, the increased expression of BAX, cleaved PARP, and cleaved caspase 3, with increased concentration of COS, conformed that COS-D3–7 and A5 induce apoptosis in BT474 cells through apoptotic signaling. We further investigated the mechanism by which COS promotes apoptosis. The marked inhibition of phosphorylation of EGFR and its downstream signaling molecules FAK, AKT, and MAPKpromote apoptosis.
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.